Women have a new weapon against postpartum depression, but it’s costly

The newly approved drug brexanolone simulates a natural steroid to alleviate symptoms

mother pushing stroller

RELIEF ON THE HORIZON  Roughly 1 in 9 women who give birth in the United States experience symptoms of postpartum depression. Now, a new drug aimed directly at treating the disorder offers new hope for finding relief.


This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Neuroscience

From the Nature Index

Paid Content